University of Birmingham Health-related quality of life in bladder cancer patients around the time of diagnosis
暂无分享,去创建一个
M. Zeegers | N. James | L. Billingham | R. Bryan | A. Wesselius | K. Cheng | D. Nekeman | E. Yu
[1] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[2] J. Catto,et al. Health-related quality of life after treatment for bladder cancer in England , 2018, British Journal of Cancer.
[3] D. Barocas,et al. Quality of Life After Radical Cystectomy. , 2018, The Urologic clinics of North America.
[4] L. Kiemeney,et al. Dietary patterns and risk of recurrence and progression in non‐muscle‐invasive bladder cancer , 2018, International journal of cancer.
[5] Byron C. Jaeger,et al. Impact of bladder cancer on health‐related quality of life , 2018, BJU international.
[6] M. Babjuk,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.
[7] M. Moran,et al. History of Cystoscopy , 2018 .
[8] G. Săraci,et al. Health Related Quality of life in bladder cancer. Current approach and future perspectives , 2017, Clujul medical.
[9] M. O'Brien,et al. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic , 2017, European journal of cancer care.
[10] V. Zadnik,et al. Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian Population , 2017, Radiology and oncology.
[11] J. Seigne,et al. THE BURDEN OF CYSTOSCOPIC BLADDER CANCER SURVEILLANCE – ANXIETY, DISCOMFORT, AND PATIENT PREFERENCES FOR DECISION MAKING: PD06‐06 , 2017, Urology.
[12] K. Franks,et al. Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13] M. Milowsky,et al. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary. , 2016, Journal of oncology practice.
[14] C. Leach,et al. Gender, race, BMI, and social support in relation to the health-related quality of life of cancer survivors: a report from the American Cancer Society’s Study of Cancer Survivors II (SCS-II) , 2016, Quality of Life Research.
[15] D. Fitzsimmons,et al. Quality‐of‐life outcomes following pelvic exenteration for primary rectal cancer , 2015, The British journal of surgery.
[16] Mary Robinson,et al. Encyclopedia of Quality of Life and Well-being Research , 2015 .
[17] N. James,et al. A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. , 2015, European urology focus.
[18] G. Lyratzopoulos,et al. Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers , 2015, British Journal of Cancer.
[19] Donna Rowen,et al. Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma , 2015, Health and Quality of Life Outcomes.
[20] Y. Lotan,et al. The economics of bladder cancer: costs and considerations of caring for this disease. , 2014, European urology.
[21] G. Boustead,et al. Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry , 2014, BJU international.
[22] K. White,et al. The effect of cancer stage and treatment modality on quality of life in oropharyngeal cancer , 2014, The Laryngoscope.
[23] A. Lopes,et al. The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? , 2014, Gynecologic oncology.
[24] U. Sambamoorthi,et al. A population‐based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender , 2013, Psycho-oncology.
[25] M. Zeegers,et al. A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years , 2013, BJU international.
[26] Giedrius Vanagas,et al. Does quality of life of prostate cancer patients differ by stage and treatment? , 2013, Scandinavian journal of public health.
[27] A. Hinz,et al. Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer , 2013, Supportive Care in Cancer.
[28] P. Fayers,et al. Comparing higher order models for the EORTC QLQ-C30 , 2011, Quality of Life Research.
[29] B. Somani,et al. Quality of Life With Urinary Diversion , 2010 .
[30] M. Zeegers,et al. The West Midlands Bladder Cancer Prognosis Programme: rationale and design , 2010, BJU international.
[31] G. Mowatt,et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. , 2010, Health technology assessment.
[32] Yair Lotan,et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. , 2009, European urology.
[33] W. Shipley,et al. Bladder cancer , 2009, The Lancet.
[34] R. Hays,et al. Impact of cancer on health-related quality of life of older Americans. , 2009, Journal of the National Cancer Institute.
[35] M. Babjuk,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.
[36] J. Haviland,et al. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). , 2007, Breast.
[37] P. Fayers,et al. Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes , 2007 .
[38] M. McGurk,et al. Head and neck cancer: to what extent can psychological factors explain differences between health-related quality of life and individual quality of life? , 2006, The British journal of oral & maxillofacial surgery.
[39] J Alfred Witjes,et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.
[40] Å. Månsson,et al. Quality of life in patients with bladder cancer. , 2005, Urologic oncology.
[41] K. Yoshimura,et al. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. , 2005, Urology.
[42] S. Fisher,et al. Prospective evaluation of quality of life in patients with oral and oropharyngeal cancer: from diagnosis to three months post-treatment. , 2004, Oral oncology.
[43] C. Pashos,et al. Quality of life aspects of bladder cancer: A review of the literature , 2003, Quality of Life Research.
[44] M. King. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.
[45] J. Ifver,et al. The Swedish Health-Related Quality of Life Survey (SWED-QUAL) , 1993, Quality of Life Research.
[46] E. Ağlamiş,et al. When should quality of life be measured after radical cystectomy? , 2002, European urology.
[47] P. Fayers. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. , 2001, European journal of cancer.
[48] A. Hinz,et al. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. , 2001, European journal of cancer.
[49] Y. Brandberg,et al. Health-related Quality of Life Measured by the EORTC QLQ-C30: Reference Values From a Large Sample of the Swedish Population , 2000 .
[50] L. Sobin,et al. Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.
[51] P. Fayers,et al. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] Michael Koller,et al. EORTC QLQ–C30 Reference Values Manual , 1998 .
[53] A. Böhle,et al. The quality of life during intravesical bacillus Calmette-Guerin therapy. , 1996, The Journal of urology.
[54] J. Ware,et al. The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. , 1995, Social science & medicine.
[55] L. Kessler,et al. Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis , 1995, Medical care.
[56] Andrew Bottomley,et al. EORTC QLQ-C30 Scoring Manual , 1995 .
[57] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[58] T. Moum,et al. Self-assessed health among Norwegian adults. , 1992, Social science & medicine.
[59] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.